English 
Deutsch 
Dr. Sennewald named as distributor for Novac7 mobile linear accelerator 
The Gold Standard in Hyperthermia 
Novac7 – The first mobile electron linear accelerator for IORT 
Quality assurance
Only the tumor cells actually heated can respond more sensitively to the radiation treatment or chemotherapy. For this reason, quality assurance, especially measurement of the temperatures in the tumor region and in normal tissue, is an indispensable aspect of hyperthermia treatment.
Dr. Oliver Ott, Radiation Therapy Clinic, University of Erlangen
Full compliance
In keeping with the quality assurance requirements for optimized treatment, all of the BSD hyperthermia systems not only have CE approval, but also comply with the guidelines of the German Society for Radiation Oncology (DEGRO) and the European Society for Hyperthermic Oncology (ESHO).
Prolonged survival rate
Only through responsible and quality-conscious application of hyperthermia in combination with chemotherapy and/or radiation treatment is it possible to increase the percentage of local remission among cancer patients as well as extend the disease-free survival rate and, to some extent, the overall survival rate.
Quality of life
The significant alleviation of pain in patients and the general improvement in the quality of life is also a major benefit of hyperthermia for patients suffering from the side effects of the cancer and the cancer treatments.
For BSD Medical Corporation, this fact is a daily incentive to improve and further develop hyperthermia systems in close cooperation with the medical community, physicists and engineers in order to improve the duration and the quality of life of cancer patients.
Udo Gaipl: Immunological and biological rationale for hyperthermia in cancer treatment